2b proteins of highly virulent cucumber mosaic virus strains are associated with suppression of DCL4 activity
Plant and Cell Physiology · 28.07.2026 · 67 (7) · 1099-1110
DOI: 10.1093/pcp/pcag036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant and Cell Physiology, online erschienen am 23.03.2026. Verfasst von Toshiyuki Fukuhara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biological Sciences, Tokyo University of Agriculture and Technology, 3-5-8 Saiwaicho, Fuchu, Tokyo 183-8509, Japan. Hauptthemen laut MEDLINE: Cucumovirus, Nicotiana, Ribonuclease III, Viral Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Global Innovation Research Organization of Tokyo University of Agriculture and Technology.
Abstract (Originalsprache)
RNA silencing constitutes a fundamental antiviral defense mechanism in plants. Although its role in virus resistance has been extensively studied, the relationship between the dicing activity of Dicer—an essential enzyme in RNA silencing—and antiviral defense remains unclear. To address this knowledge gap, we previously established a simple in vitro dicing assay that enables the direct assessment of the activities of two Dicers, DCL3 and DCL4. We hypothesized that this assay could reveal how viral infection modulates DCL3 and DCL4 activities. Here, we report a negative correlation between NbDCL4 activity and symptom severity using the Nicotiana benthamiana–cucumber mosaic virus (CMV) system. We demonstrate that NbDCL4 activity is specifically suppressed in plants infected with highly virulent subgroup I (sg I) strains of CMV. In vitro dicing assays and small RNA sequencing analyses further reveal that NbDCL4 activity toward long double-stranded RNA (dsRNA) remains unaffected, whereas its activity toward shorter dsRNAs (~50 nt) is markedly inhibited in CMV(sg I)-infected plants. Subsequent analyses using a 2b-deficient disarmed mutant and a less virulent subgroup II strain of CMV indicate that this inhibition is mediated by the sg I 2b protein, a viral suppressor of RNA silencing. Taken together, these findings provide mechanistic insights into the molecular basis of CMV virulence, suggesting that the severe symptoms induced by highly virulent CMV strains are, at least in part, attributable to 2b-mediated inhibition of DCL4 activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biological Sciences, Tokyo University of Agriculture and Technology, 3-5-8 Saiwaicho, Fuchu, Tokyo 183-8509, Japan.
- Institute of Global Innovation Research, Tokyo University of Agriculture and Technology, 3-5-8 Saiwaicho, Fuchu, Tokyo 183-8509, Japan.
- Graduate School of Agricultural Science, Tohoku University, 468-1, Aramaki-Aza-Aoba, Sendai 980-0845, Japan.
- Institute of Plant Science and Resources, Okayama University, Kurashiki, Okayama 710-0046, Japan.
ORCID-Profile: Toshiyuki Fukuhara
Förderung
- Japan Society for the Promotion of Science
- Global Innovation Research Organization of Tokyo University of Agriculture and Technology
Zitieren
APA
Fukuhara, T., Miyashita, S., Suzuki, N., & Takahashi, H. (2026). 2b proteins of highly virulent cucumber mosaic virus strains are associated with suppression of DCL4 activity. Plant and Cell Physiology, 67(7), 1099-1110. https://doi.org/10.1093/pcp/pcag036
Vancouver
Fukuhara T, Miyashita S, Suzuki N, Takahashi H. 2b proteins of highly virulent cucumber mosaic virus strains are associated with suppression of DCL4 activity. Plant and Cell Physiology. 2026;67(7):1099-1110. doi:10.1093/pcp/pcag036
BibTeX
@article{Fukuhara2026,
author = {Fukuhara, Toshiyuki and Miyashita, Shuhei and Suzuki, Nobuhiro and Takahashi, Hideki},
title = {2b proteins of highly virulent cucumber mosaic virus strains are associated with suppression of DCL4 activity},
journal = {Plant and Cell Physiology},
year = {2026},
volume = {67},
number = {7},
pages = {1099--1110},
doi = {10.1093/pcp/pcag036}
}
EUVIMED